Hester E. de Melker

ORCID: 0000-0001-9100-1639
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Vaccine Coverage and Hesitancy
  • Influenza Virus Research Studies
  • Bacterial Infections and Vaccines
  • SARS-CoV-2 and COVID-19 Research
  • Virology and Viral Diseases
  • Cervical Cancer and HPV Research
  • Pneumonia and Respiratory Infections
  • COVID-19 epidemiological studies
  • Hepatitis B Virus Studies
  • Respiratory viral infections research
  • Herpesvirus Infections and Treatments
  • Genital Health and Disease
  • COVID-19 Clinical Research Studies
  • Diphtheria, Corynebacterium, and Tetanus
  • Viral gastroenteritis research and epidemiology
  • COVID-19 and Mental Health
  • Syphilis Diagnosis and Treatment
  • Vector-borne infectious diseases
  • Cytomegalovirus and herpesvirus research
  • COVID-19 and healthcare impacts
  • Hepatitis Viruses Studies and Epidemiology
  • Data-Driven Disease Surveillance
  • Poxvirus research and outbreaks
  • Animal Virus Infections Studies
  • Long-Term Effects of COVID-19

National Institute for Public Health and the Environment
2015-2024

Eindhoven Cancer Registry
2002-2023

Netherlands Organisation for Applied Scientific Research
2020

Health Forecasting
2009-2019

Dutch Expert Centre for Screening
2019

Amsterdam UMC Location University of Amsterdam
2019

Maastricht University
2017

European Centre for Disease Prevention and Control
2014

In-Q-Tel
2012

University Medical Center Utrecht
2009

We present early vaccine effectiveness (VE) estimates of the 2023 seasonal COVID-19 XBB.1.5 against hospitalisation and admission to an intensive care unit (ICU) in previously vaccinated adults ≥ 60 years Netherlands. compared vaccination status 2,050 hospitalisations including 92 ICU admissions with age group-, sex-, region- date-specific population coverage between 9 October 5 December 2023. VE was 70.7% (95% CI: 66.6–74.3), 73.3% 42.2–87.6).

10.2807/1560-7917.es.2024.29.1.2300703 article EN cc-by Eurosurveillance 2024-01-04

Laboratory confirmation of pertussis by culture, PCR, or detection antibody increase in paired sera is hampered low sensitivity the later stages disease. Therefore, we investigated whether, and at which level, concentrations immunoglobulin G (IgG) antibodies against toxin (PT), IgG-PT, a single serum sample are indicative active recent pertussis. measured enzyme-linked immunosorbent assay units per milliliter, was analyzed 7,756 collected population-based study The Netherlands, 3,491...

10.1128/jcm.38.2.800-806.2000 article EN Journal of Clinical Microbiology 2000-02-01

We analyzed pertussis reporting, death, hospitalization, and serodiagnostic data from 1976 to 1998 help explain the cause of 1996 outbreak in Netherlands. The unexpected was detected by an increase reporting other surveillance methods. In 1996, according serologic data, incidence among (mostly unvaccinated) children less than 1 year age similar hospital admissions. Among older vaccinated) persons, admissions relatively small. higher vaccinated unvaccinated persons all ages. This resulted...

10.3201/eid0604.000404 article EN cc-by Emerging infectious diseases 2000-08-01

In high income countries, vaccine-preventable diseases have been greatly reduced through routine vaccination programs. Despite this success, many parents question, and a small proportion even refuse for their children. As no qualitative studies explored the factors behind these decisions among Dutch parents, we performed study using online focus groups.In total, eight groups (n = 60) which included with at least one child, aged 0-4 years, whom they refused all or part of vaccinations within...

10.1186/1471-2458-13-1183 article EN cc-by BMC Public Health 2013-12-01

Background: In May 2013, a measles outbreak began in the Netherlands among Orthodox Protestants who often refuse vaccination for religious reasons. Objective: Our aim was to compare number of messages expressed on Twitter and other social media during with online news articles reported cases answer question if when reflect public opinion patterns versus disease patterns. Methods: We analyzed measles-related tweets, messages, newspaper over 7-month period (April 15 November 11, 2013) regard...

10.2196/jmir.3863 article EN cc-by Journal of Medical Internet Research 2015-05-26

Little is known about the time span of progression from high-grade cervical intraepithelial neoplasia (CIN2/3) to invasive cancer. Estimation this duration longitudinal studies not permitted, as CIN2/3 should be treated when detected. Cross-sectional data on age-specific incidence detected and cancer cases are readily available in national registries, but these difficult interpret because neither moment lesion development nor onset observed. We developed a statistical model for estimating...

10.1093/aje/kwt077 article EN American Journal of Epidemiology 2013-07-28

Background We aimed to detect SARS-CoV-2 serum antibodies in the general population of Netherlands and identify risk factors for seropositivity amidst first COVID-19 epidemic wave. Methods Participants (n=3207, aged 2–90 years), enrolled from a previously established nationwide serosurveillance study, provided self-collected fingerstick blood sample completed questionnaire (median inclusion date 3 April 2020). IgG targeted against spike S1-protein were quantified using validated...

10.1136/jech-2020-215678 article EN cc-by Journal of Epidemiology & Community Health 2020-11-28

Discrete Choice Experiments (DCEs) are increasingly used in studies healthcare research but there is still little empirical evidence for the predictive value of these hypothetical situations similar real life circumstances. The aim this paper to compare stated preferences a DCE and accompanying questionnaire with revealed young parents who have decide whether vaccinate their new born child against hepatitis B. A asking which scenario they would be more inclined preference was estimated by...

10.1186/s12874-015-0010-5 article EN cc-by BMC Medical Research Methodology 2015-03-11

BackgroundDuring the COVID-19 pandemic, many countries have implemented physical distancing measures to reduce transmission of SARS-CoV-2.AimTo measure actual reduction contacts when are implemented.MethodsA cross-sectional survey was carried out in Netherlands 2016-17, which participants reported number and age their previous day. The repeated among a subsample April 2020, after strict were implemented, an extended sample June some relaxed.ResultsThe average community per day reduced from...

10.2807/1560-7917.es.2021.26.8.2000994 article EN cc-by Eurosurveillance 2021-02-25

Abstract Background PIENTER 3 (P3), conducted in 2016/17, is the most recent of three nationwide serological surveys Netherlands. The aim to monitor effects National Immunisation Programme (NIP) by assessing population seroprevalence included vaccine preventable diseases (VPDs). response rate main sample was 15.7% ( n = 4,983), following a decreasing trend compared previous two studies (P1, 55.0%; 1995/1996 [ 8,356] and P2, 33.0%; 2006/2007 5,834]). Non-responders P3 survey were followed-up...

10.1186/s12879-024-09095-5 article EN cc-by BMC Infectious Diseases 2024-02-23

In 1996, a sudden increase in pertussis incidence was reported the Netherlands (2.1 per 100,000 1995, 18 1996). Although not all potential surveillance artifacts could be excluded, it is highly probable that data reflect true outbreak. However, cause of this has yet been determined. Further research directed to severity disease and possible mismatch between vaccine circulating Bordetella strains.

10.3201/eid0302.970211 article EN Emerging infectious diseases 1997-06-01

High titres of pertussis toxin (PT) antibody have been shown to be predictive recent infection with Bordetella pertussis. The seroprevalence standardized anti-PT was determined in six Western European countries between 1994 and 1998 related historical surveillance vaccine programme data. Standardized were calculated for a series whole-cell acellular trials. For the serological surveys, high-titre sera (> 125 units/ml) distributed throughout all age groups both high- 90%) low-coverage (<...

10.1017/s0950268804003012 article EN Epidemiology and Infection 2004-09-27

Routine vaccination with a single dose of conjugated meningococcal C vaccine at 14 months and catch-up campaign have reduced the incidence disease in Netherlands. In contrast to countries where routine is given infancy, failures were not reported. This suggests that one second year life might offer longer lasting protection against than 3 doses infancy.

10.1097/01.inf.0000195594.41449.c6 article EN The Pediatric Infectious Disease Journal 2006-01-01

To analyze the epidemiology of a nationwide mumps epidemic in Netherlands, we reviewed 1,557 notified cases persons who had disease onset during September 1, 2009-August 31, 2012. Seasonality peaked spring and autumn. Most case-patients were males (59%), 18-25 years age (67.9%), vaccinated twice with measles-mumps-rubella vaccine (67.7%). Nearly half (46.6%) occurred university students or student contacts. Receipt 2 doses reduced risk for orchitis, most frequently reported complication...

10.3201/eid2004.131681 article EN cc-by Emerging infectious diseases 2014-02-27

Since 2009, the incidence of meningococcal serogroup W disease has increased rapidly in UK because a single strain (the so-called original strain) belonging to hypervirulent sequence type-11 clonal complex (cc11), with variant outbreak 2013 emerging 2013. Subsequently, Netherlands had an increase disease. We assessed temporal and phylogenetic associations between outbreaks England, historical C both countries.For this observational cohort study, we used national surveillance data for England...

10.1016/s2468-2667(17)30157-3 article EN cc-by-nc-nd The Lancet Public Health 2017-08-25

Aim This study aimed to estimate long‐term impairment attributable congenital cytomegalovirus infection ( cCMV ). Method nationwide cohort retrospectively assessed in children born 2008 the Netherlands, testing 31 484 stored neonatal dried blood spots. Extensive medical data of ‐positive n =133) and matched ‐negative comparison =274) up 6 years age were analysed. Results Moderate severe was diagnosed 24.8% (33 out 133) all (53.8% symptomatic, 17.8% asymptomatic), compared with 12.0% 274)...

10.1111/dmcn.13556 article EN Developmental Medicine & Child Neurology 2017-10-09

Immunization schedules with pneumococcal conjugate vaccine (PCV) differ among countries regarding the number of doses, age at vaccinations, and interval between doses.To assess optimal primary vaccination schedule by comparing immunogenicity 13-valent PCV (PCV13) in 4 different immunization schedules.An open-label, parallel-group, randomized clinical trial healthy term infants a general community The Netherlands conducted June 30, 2010, January 25, 2011, 99% follow-up until 12 months.Infants...

10.1001/jama.2013.228052 article EN JAMA 2013-09-03
Petra J. Woestenberg Audrey J. King Birgit van Benthem Robine Donken Suzan Leussink and 95 more Fiona van der Klis Hester E. de Melker Marianne A. B. van der Sande Christian J. P. A. Hoebe Johannes A. Bogaards D. Adema R. Buist-Arkema A. Beerens Dirk Luijt S. Meijer Jurjen Schirm Marc Peeters John W. A. Rossen Harold Verbakel Patrick van Esch Jaco J. Verweij Annemiek van der Eijk R. M. Huisman C. M. C. Kerkhof H. Korff Martin Schutten Jans Velzing F. Verduyn-Lunel S. Lakbiach Peter van Rosmalen Rob Schuurman D. Abma Katherine Adams Sylvia M. Bruisten Ian van der Linde Paul M. Oostvogel C. Touwen W Vermeulen Antoinette A. T. P. Brink Jelly Nelissen Petra Wolffs N. Duijvendijk Peter M. Schneeberger Manfred Pöppel Willem J. G. Melchers Y. Poort M. Hooghiemstra Han G. Huisman Jan Weel F Bosma Felix Geeraedts I. Polman P van Goor M. J. H. M. Wolfhagen C. de Mooij Elly van Koolwijk Michael H. Peters C.M.A. Swanink R. Tiemessen TL van Zwet J Janssen M Pelsers W. de Waal G. Aalfs Jordy J. S. Kiewiet P. Sanders H. van Buel-Bruins C. van Bokhoven-Rombouts P. J. G. Cornelissen Marie José Kersten C. van Ruitenbeek I. Quintus Molenaar Eva van Doorn L. J. Masthoff E. Pannekoek V. Sigurdsson M.L.T. Bugter Hannelore M Götz M. Illidge-Onder de Linden M. Mattijssen J. Stam E. Swaders F de Groot F. Postma Elfi E. H. G. Brouwers Anne-Marie Niekamp Marieke Smit A. Botraby D. Bukasa C. de Haan P. Hut-van Vliet T. Taconis M. de Graas I. Hondelink Carolina J. G. Kampman A. Gelissen-Hansen Inge de Koning H. van Kruchten M. van de Pas H Fennema

Observational postmarketing studies are important to assess vaccine effectiveness (VE). We estimated VE from the bivalent human papillomavirus (HPV) against HPV positivity of and nonvaccine types in a high-risk population.We included all vaccine-eligible women PASSYON study, biennial cross-sectional survey Dutch sexually transmitted infection clinics. Vaginal swabs were analyzed using polymerase chain reaction-based assay (SPF10-LiPA25) able detect 12 (hrHPV)...

10.1093/infdis/jix582 article EN cc-by-nc-nd The Journal of Infectious Diseases 2017-11-06
Coming Soon ...